These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 31296961)

  • 1. Downregulation of FOXO3a by DNMT1 promotes breast cancer stem cell properties and tumorigenesis.
    Liu H; Song Y; Qiu H; Liu Y; Luo K; Yi Y; Jiang G; Lu M; Zhang Z; Yin J; Zeng S; Chen X; Deng M; Jia X; Gu Y; Chen D; Zheng G; He Z
    Cell Death Differ; 2020 Mar; 27(3):966-983. PubMed ID: 31296961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXM1 recruits nuclear Aurora kinase A to participate in a positive feedback loop essential for the self-renewal of breast cancer stem cells.
    Yang N; Wang C; Wang Z; Zona S; Lin SX; Wang X; Yan M; Zheng FM; Li SS; Xu B; Bella L; Yong JS; Lam EW; Liu Q
    Oncogene; 2017 Jun; 36(24):3428-3440. PubMed ID: 28114286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activin and Hepatocyte Growth Factor Promotes Colorectal Cancer Stemness and Metastasis through FOXM1/SOX2/CXCR4 Signaling.
    Peng H; Ye T; Deng L; Yang X; Li Q; Tong J; Guo J
    Gut Liver; 2024 May; 18(3):476-488. PubMed ID: 37458065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gain-of-function mutant p53 promotes the oncogenic potential of head and neck squamous cell carcinoma cells by targeting the transcription factors FOXO3a and FOXM1.
    Tanaka N; Zhao M; Tang L; Patel AA; Xi Q; Van HT; Takahashi H; Osman AA; Zhang J; Wang J; Myers JN; Zhou G
    Oncogene; 2018 Mar; 37(10):1279-1292. PubMed ID: 29269868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA-128-3p overexpression inhibits breast cancer stem cell characteristics through suppression of Wnt signalling pathway by down-regulating NEK2.
    Chen Y; Wu N; Liu L; Dong H; Liu X
    J Cell Mol Med; 2020 Jul; 24(13):7353-7369. PubMed ID: 32558224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer.
    McGovern UB; Francis RE; Peck B; Guest SK; Wang J; Myatt SS; Krol J; Kwok JM; Polychronis A; Coombes RC; Lam EW
    Mol Cancer Ther; 2009 Mar; 8(3):582-91. PubMed ID: 19276163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2.
    Lee Y; Kim KH; Kim DG; Cho HJ; Kim Y; Rheey J; Shin K; Seo YJ; Choi YS; Lee JI; Lee J; Joo KM; Nam DH
    PLoS One; 2015; 10(10):e0137703. PubMed ID: 26444992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation and not H3K4 trimethylation dictates the expression status of miR-152 gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop.
    Sengupta D; Deb M; Rath SK; Kar S; Parbin S; Pradhan N; Patra SK
    Exp Cell Res; 2016 Aug; 346(2):176-87. PubMed ID: 27475839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FoxM1 promotes breast tumorigenesis by activating PDGF-A and forming a positive feedback loop with the PDGF/AKT signaling pathway.
    Yu G; Zhou A; Xue J; Huang C; Zhang X; Kang SH; Chiu WT; Tan C; Xie K; Wang J; Huang S
    Oncotarget; 2015 May; 6(13):11281-94. PubMed ID: 25869208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA HOTTIP facilitates the stemness of breast cancer via regulation of miR-148a-3p/WNT1 pathway.
    Han L; Yan Y; Zhao L; Liu Y; Lv X; Zhang L; Zhao Y; Zhao H; He M; Wei M
    J Cell Mol Med; 2020 Jun; 24(11):6242-6252. PubMed ID: 32307830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An integrated genomic approach identifies that the PI3K/AKT/FOXO pathway is involved in breast cancer tumor initiation.
    Smit L; Berns K; Spence K; Ryder WD; Zeps N; Madiredjo M; Beijersbergen R; Bernards R; Clarke RB
    Oncotarget; 2016 Jan; 7(3):2596-610. PubMed ID: 26595803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. hTERT promotes the invasion of gastric cancer cells by enhancing FOXO3a ubiquitination and subsequent ITGB1 upregulation.
    Hu C; Ni Z; Li BS; Yong X; Yang X; Zhang JW; Zhang D; Qin Y; Jie MM; Dong H; Li S; He F; Yang SM
    Gut; 2017 Jan; 66(1):31-42. PubMed ID: 26370108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of FOXM1 and related proteins in breast cancer molecular subtypes.
    Lee JJ; Lee HJ; Son BH; Kim SB; Ahn JH; Ahn SD; Cho EY; Gong G
    Int J Exp Pathol; 2016 Apr; 97(2):170-7. PubMed ID: 27277416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA IGF2-AS represses breast cancer tumorigenesis by epigenetically regulating IGF2.
    Zhang Y; Yan H; Jiang Y; Chen T; Ma Z; Li F; Lin M; Xu Y; Zhang X; Zhang J; He H
    Exp Biol Med (Maywood); 2021 Feb; 246(4):371-379. PubMed ID: 33175607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing transcription factor FOXM1 represses proliferation, migration, and invasion while inducing apoptosis of liver cancer stem cells by regulating the expression of ALDH2.
    Chen L; Wu M; Ji C; Yuan M; Liu C; Yin Q
    IUBMB Life; 2020 Feb; 72(2):285-295. PubMed ID: 31580537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear Factor Erythroid-Derived 2-Like 2-Induced Reductive Stress Favors Self-Renewal of Breast Cancer Stem-Like Cells
    Kim DH; Jang JH; Kwon OS; Cha HJ; Youn HJ; Chun KS; Surh YJ
    Antioxid Redox Signal; 2020 Jun; 32(18):1313-1329. PubMed ID: 31672029
    [No Abstract]   [Full Text] [Related]  

  • 17. FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer.
    Karadedou CT; Gomes AR; Chen J; Petkovic M; Ho KK; Zwolinska AK; Feltes A; Wong SY; Chan KY; Cheung YN; Tsang JW; Brosens JJ; Khoo US; Lam EW
    Oncogene; 2012 Apr; 31(14):1845-58. PubMed ID: 21860419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNMT1 is essential for mammary and cancer stem cell maintenance and tumorigenesis.
    Pathania R; Ramachandran S; Elangovan S; Padia R; Yang P; Cinghu S; Veeranan-Karmegam R; Arjunan P; Gnana-Prakasam JP; Sadanand F; Pei L; Chang CS; Choi JH; Shi H; Manicassamy S; Prasad PD; Sharma S; Ganapathy V; Jothi R; Thangaraju M
    Nat Commun; 2015 Apr; 6():6910. PubMed ID: 25908435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of forkhead box M1 is associated with aggressive phenotype and poor prognosis in estrogen receptor-positive breast cancer.
    Ahn H; Sim J; Abdul R; Chung MS; Paik SS; Oh YH; Park CK; Jang K
    J Korean Med Sci; 2015 Apr; 30(4):390-7. PubMed ID: 25829806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Casticin suppresses the carcinogenesis of small cell lung cancer H446 cells through activation of AMPK/FoxO3a signaling.
    Gong Q; Cao X; Cao J; Yang X; Zeng W
    Oncol Rep; 2018 Sep; 40(3):1401-1410. PubMed ID: 30015975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.